Sustained oral indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced renal cell carcinoma.
Saved in:
| Title: | Sustained oral indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced renal cell carcinoma. |
|---|---|
| Authors: | Mertens WC; Department of Medical Oncology, London Regional Cancer Centre, Ontario, Canada., Bramwell VH, Banerjee D, Gwadry-Sridhar F, al-Mutter N, Parhar RS, Lala PK |
| Source: | Cancer biotherapy [Cancer Biother] 1993 Fall; Vol. 8 (3), pp. 229-33. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9314021 Publication Model: Print Cited Medium: Print ISSN: 1062-8401 (Print) Linking ISSN: 10628401 NLM ISO Abbreviation: Cancer Biother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
